# Integrated Diagnostics Holdings Plc (IDHC.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Healthcare / Biotechnology. Price $0.54, market value $313 million.

## Valuation
- **P/E (trailing): 10.8×** (5-yr avg 0.4×, 3-yr avg 0.3×). Integrated Diagnostics Holdings Plc trades at 10.8× trailing earnings, well above its own five-year average of 0.4×: investors are paying up relative to the company's past. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 0.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.02**. A PEG of 0.02 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / book: 0.1×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Earnings yield: 9.3%**. The inverse of the P/E: 9.3% of the price is earned each year.

## Profitability
- **Gross margin: 41.9%**. Integrated Diagnostics Holdings Plc keeps 41.9% of revenue after the direct cost of what it sells.
- **Operating margin: 26.6%**. 26.6% of revenue is left after running the business, an exceptional level.
- **Net margin: 16.1%**. 16.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 37.3%**. 37.3% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 44.9%**. Return on all capital, debt included, is 44.9%: comfortably above what that capital costs.
- **Return on assets: 16.3%**. Each dollar of assets produces 16.3% of profit.

## Growth
- **Revenue growth (1 yr): 37.3%** (3-yr 29.6%/yr, 5-yr 24.2%/yr). Revenue grew 37.3% over the last year, against 24.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 19.2%** (3-yr 34.1%/yr, 5-yr 17.0%/yr). Earnings per share rose 19.2%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.48**. Debt is 0.48 times equity: a conservative balance sheet.
- **Current ratio: 1.46** (quick 1.31). Current assets cover the next year's liabilities 1.46 times.
- **Altman Z-score: 2.50**. A Z-score of 2.50 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.55%** ($0.01 per share, trailing). Integrated Diagnostics Holdings Plc yields 1.55%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 42%** (1% of free cash flow). 42% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 1**. 1 straight year of increases.
- **Dividend growth (5 yr): -18.3%/yr**. The dividend has not grown over five years.

## Price and momentum
- **Total return (1 yr): 19.0%** (YTD -26.4%, 3-mo 0.0%). The shares are up 19.0% over twelve months including dividends.
- **From 52-week high: -35.6%** (22.3% above the low). Trading 36% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 0.10** (volatility 57%). Beta of 0.10 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=IDHC.L · Page: https://foliofundamentals.com/stocks/idhc.l

Not investment advice.